<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32907809</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-905X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Clinical journal of the American Society of Nephrology : CJASN</Title><ISOAbbreviation>Clin J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>IgE-Mediated Immune Response and Antibody-Mediated Rejection.</ArticleTitle><Pagination><StartPage>1474</StartPage><EndPage>1483</EndPage><MedlinePgn>1474-1483</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2215/CJN.02870320</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Active antibody-mediated rejection is the main cause of kidney transplant loss, sharing with SLE the alloimmune response and the systemic activation of the IFN-<i>&#x3b1;</i> pathway. IgE-mediated immune response plays a key role in the development of SLE nephritis and is associated with IFN-<i>&#x3b1;</i> secretion. The aim of our study was to investigate IgE-mediated immune response in antibody-mediated rejection.</AbstractText><AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS">This was a cross-sectional study of 56 biopsy-proven antibody-mediated rejection study participants, 80 recipients with normal graft function/histology (control), 16 study participants with interstitial fibrosis/tubular atrophy, and six participants with SLE. We evaluated graft IgE deposition, tryptase (a mast cell marker), and CD203 (a specific marker of activated basophils) by immunofluorescence/confocal microscopy. In addition, we measured serum concentration of human myxovirus resistance protein 1, an IFN-<i>&#x3b1;-</i>induced protein, and anti-HLA IgE.</AbstractText><AbstractText Label="RESULTS">We observed a significantly higher IgE deposition in tubules and glomeruli in antibody-mediated rejection (1766&#xb1;79 pixels) and SLE (1495&#xb1;43 pixels) compared with interstitial fibrosis/tubular atrophy (582&#xb1;122 pixels) and control (253&#xb1;50 pixels). Patients with antibody-mediated rejection, but not control patients and patients with interstitial fibrosis/tubular atrophy, presented circulating anti-HLA IgE antibodies, although with a low mean fluorescence intensity. In addition, immunofluorescence revealed the presence of both mast cells and activated basophils in antibody-mediated rejection but not in control and interstitial fibrosis/tubular atrophy. The concentration of circulating basophils was significantly higher in antibody-mediated rejection compared with control and interstitial fibrosis/tubular atrophy. MxA serum levels were significantly higher in antibody-mediated rejection compared with control and correlated with the extent of IgE deposition.</AbstractText><AbstractText Label="CONCLUSIONS">Our data suggest that IgE deposition and the subsequent recruitment of basophils and mast cells within the kidney transplant might play a role in antibody-mediated rejection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the American Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rascio</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Nephrology Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontrelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, Nephrology, Dialysis and Transplantation Unit, University of Bari "A. Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Netti</LastName><ForeName>Giuseppe Stefano</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Clinical Pathology Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manno</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Nephrology Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Infante</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Nephrology Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simone</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, Nephrology, Dialysis and Transplantation Unit, University of Bari "A. Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Nephrology Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Clinical Pathology Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seveso</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Sciences, Transplant Immunology Unit, Padova University Hospital, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzi</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic and Vascular Sciences, Transplant Immunology Unit, Padova University Hospital, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gesualdo</LastName><ForeName>Loreto</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Emergency and Organ Transplantation, Nephrology, Dialysis and Transplantation Unit, University of Bari "A. Moro," Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallone</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Nephrology Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandaliano</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine and Surgery, Nephrology Unit, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Nephrology Unit, Fondazione Policlinico Universitario "A. Gemelli" Scientific Institute of Recovery and Care, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Am Soc Nephrol</MedlineTA><NlmUniqueID>101271570</NlmUniqueID><ISSNLinking>1555-9041</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579071">MX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064547">Myxovirus Resistance Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance UI="D007073">Immunoglobulin E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1392-1393</RefSource><PMID Version="1">33028604</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064591" MajorTopicYN="N">Allografts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001491" MajorTopicYN="N">Basophils</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006084" MajorTopicYN="N">Graft Rejection</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007073" MajorTopicYN="N">Immunoglobulin E</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007678" MajorTopicYN="N">Kidney Glomerulus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="N">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007684" MajorTopicYN="N">Kidney Tubules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064547" MajorTopicYN="N">Myxovirus Resistance Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IgE</Keyword><Keyword MajorTopicYN="N">basophils</Keyword><Keyword MajorTopicYN="N">chronic rejection</Keyword><Keyword MajorTopicYN="N">interferon alpha</Keyword><Keyword MajorTopicYN="N">mast cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32907809</ArticleId><ArticleId IdType="pmc">PMC7536744</ArticleId><ArticleId IdType="doi">10.2215/CJN.02870320</ArticleId><ArticleId IdType="pii">01277230-202010000-00014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maurer M, Altrichter S, Schmetzer O, Scheffel J, Church MK, Metz M: Immunoglobulin E-mediated autoimmunity. Front Immunol 9: 689, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900004</ArticleId><ArticleId IdType="pubmed">29686678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettinger R, Karnell JL, Henault J, Panda SK, Riggs JM, Kolbeck R, Sanjuan MA: Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses. Autoimmunity 50: 25&#x2013;36, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28166684</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;nnblom L, Elkon KB: Cytokines as therapeutic targets in SLE. Nat Rev Rheumatol 6: 339&#x2013;347, 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20440285</ArticleId></ArticleIdList></Reference><Reference><Citation>Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML: Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res 37: 1497&#x2013;1501, 2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448870</ArticleId></ArticleIdList></Reference><Reference><Citation>Atta AM, Santiago MB, Guerra FG, Pereira MM, Sousa Atta ML: Autoimmune response of IgE antibodies to cellular self-antigens in systemic lupus erythematosus. Int Arch Allergy Immunol 152: 401&#x2013;406, 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20197682</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles N, Hardwick D, Daugas E, Illei GG, Rivera J: Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 16: 701&#x2013;707, 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2909583</ArticleId><ArticleId IdType="pubmed">20512127</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch X, Lozano F, Cervera R, Ramos-Casals M, Min B: Basophils, IgE, and autoantibody-mediated kidney disease. J Immunol 186: 6083&#x2013;6090, 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466044</ArticleId><ArticleId IdType="pubmed">21597041</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto JF, Truchetet ME, Charles N, Blanco P, Richez C: IgE in lupus pathogenesis: Friends or foes? Autoimmun Rev 17: 361&#x2013;365, 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29425937</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C; F&#xe9;d&#xe9;ration Hospitalo-Universitaire ACRONIM : IgE inhibits Toll-like receptor 7- and Toll-like receptor 9-mediated expression of Interferon-&#x3b1; by plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Arthritis Rheumatol 68: 2221&#x2013;2231, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">26991804</ArticleId></ArticleIdList></Reference><Reference><Citation>Henault J, Riggs JM, Karnell JL, Liarski VM, Li J, Shirinian L, Xu L, Casey KA, Smith MA, Khatry DB, Izhak L, Clarke L, Herbst R, Ettinger R, Petri M, Clark MR, Mustelin T, Kolbeck R, Sanjuan MA: Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol 17: 196&#x2013;203, 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718782</ArticleId><ArticleId IdType="pubmed">26692173</ArticleId></ArticleIdList></Reference><Reference><Citation>Loupy A, Hill GS, Jordan SC: The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 8: 348&#x2013;357, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22508180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin YP, Valenzuela NM, Zhang X, Rozengurt E, Reed EF: HLA class II-triggered signaling cascades cause endothelial cell proliferation and Migration: Relevance to antibody-mediated transplant rejection. J Immunol 200: 2372&#x2013;2390, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860975</ArticleId><ArticleId IdType="pubmed">29475988</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascio F, Pontrelli P, Accetturo M, Oranger A, Gigante M, Castellano G, Gigante M, Zito A, Zaza G, Lupo A, Ranieri E, Stallone G, Gesualdo L, Grandaliano G: A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. J Pathol 237: 72&#x2013;84, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25925804</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaunat O, Graff-Dubois S, Fabien N, Duthey A, Attuil-Audenis V, Nicoletti A, Patey N, Morelon E: A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection. Kidney Int 81: 207&#x2013;219, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">21937978</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M; Banff meeting report writing committee : Banff 2013 meeting report: Inclusion of C4D-negative antibody-mediated rejection and antibody-associated arterial lesions [published correction appears in Am J Transplant 15: 2784, 2015]. Am J Transplant 14: 272&#x2013;283, 2014.</Citation><ArticleIdList><ArticleId IdType="pubmed">24472190</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkas AM, Baranyi U, B&#xf6;hmig GA, Unger L, Hopf S, Wahrmann M, Regele H, Mahr B, Schwarz C, Hock K, Pilat N, Kristo I, Mraz J, Lupinek C, Thalhamer J, Bond G, Kuessel L, Wlodek E, Martin J, Clatworthy M, Pettigrew G, Valenta R, Wekerle T: Allograft rejection is associated with development of functional IgE specific for donor MHC antigens. J Allergy Clin Immunol 143: 335&#x2013;345.e12, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30009843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiefer K, Oropallo MA, Cancro MP, Marshak-Rothstein A: Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol 90: 498&#x2013;504, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701256</ArticleId><ArticleId IdType="pubmed">22430248</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol CL, Medzhitov R: Emerging functions of basophils in protective and allergic immune responses. Mucosal Immunol 3: 129&#x2013;137, 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20072123</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers J, Rothenberg ME: Eosinophils in mucosal immune responses. Mucosal Immunol 8: 464&#x2013;475, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4476057</ArticleId><ArticleId IdType="pubmed">25807184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellefigues C, Charles N: The deleterious role of basophils in systemic lupus erythematosus. Curr Opin Immunol 25: 704&#x2013;711, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3876474</ArticleId><ArticleId IdType="pubmed">24209595</ArticleId></ArticleIdList></Reference><Reference><Citation>Colvin RB, Dvorak HF: Letter: Basophils and mast cells in renal allograft rejection. Lancet 1: 212&#x2013;214, 1974.</Citation><ArticleIdList><ArticleId IdType="pubmed">4129893</ArticleId></ArticleIdList></Reference><Reference><Citation>Egido J, Crespo M, Sanchez MG, Hernando L, Benveniste J: In-vitro basophil degranulation in drug-suspected acute renal failure. Lancet 2: 712&#x2013;713, 1977.</Citation><ArticleIdList><ArticleId IdType="pubmed">71519</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;hring HJ, Streble A, Valent P: The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 133: 317&#x2013;329, 2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">15031605</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandaliano G, Pontrelli P, Cerullo G, Monno R, Ranieri E, Ursi M, Loverre A, Gesualdo L, Schena FP: Protease-activated receptor-2 expression in IgA nephropathy: A potential role in the pathogenesis of interstitial fibrosis. J Am Soc Nephrol 14: 2072&#x2013;2083, 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">12874461</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto E, Honjo S, Yamashita H, Shomori K, Adachi H, Ito H: Mast cells in human allografted kidney: Correlation with interstitial fibrosis. Clin Transplant 16[Suppl 8]: 7&#x2013;11, 2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">12464125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengel M, Reeve J, Bunnag S, Einecke G, Sis B, Mueller T, Kaplan B, Halloran PF: Molecular correlates of scarring in kidney transplants: The emergence of mast cell transcripts. Am J Transplant 9: 169&#x2013;178, 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">18976290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>